Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03031301 · ClinicalTrials.gov registry record · NA

A Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week

A NA study, sponsored by Vibrant.

Completed
Registry status
NA
Development phase
182
Enrollment target

NCT03031301 is a NA study that has completed, run by Vibrant. The registered enrollment target is 182 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03031301, a NA study, has completed, sponsored by Vibrant.

COMPLETED
Registry status
NA
Development phase
182 participants
Enrollment target

Study Summary

The study is a prospective, adaptive, multicenter, randomized, double-blind, Sham-controlled study, to evaluate the efficacy and safety of the Vibrant Capsule in relieving constipation in subjects with functional constipation. Two arms will be assessed: * Vibrant Capsule administered 5 times per week * Sham Capsule administered 5 times per week

Interventions

  • DEVICE Vibrant capsule
  • DEVICE Sham capsule

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2017-02-01
Est. Completion 2018-07-30
Phase NA

Sponsor

Vibrant

8 total trials

What the Registry Record Tells You About NCT03031301

The ClinicalTrials.gov registry entry for NCT03031301 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vibrant, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Vibrant capsule is the first listed.

NCT03031301 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03031301 about?

NCT03031301 is a clinical study titled "A Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week". The study is a prospective, adaptive, multicenter, randomized, double-blind, Sham-controlled study, to evaluate the efficacy and safety of the Vibrant Capsule in relieving constipation in subjects with functional constipation. Two arms will be assessed: * Vibrant Capsule administered 5 times per w...

What is the current status of trial NCT03031301?

This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2017-02-01. Estimated completion is 2018-07-30.

What interventions are being tested in trial NCT03031301?

The interventions under investigation include: Vibrant capsule (DEVICE), Sham capsule (DEVICE).

Who is sponsoring clinical trial NCT03031301?

This trial is sponsored by Vibrant, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.